Outcomes and quality of life after Robot-assisted lobectomy/segmentectomy for lung cancer compared to video-assisted thoracoscopic surgery: both three-port procedures performed by a single surgeon

被引:17
作者
Zheng, Liang
Song, Peng
Jiang, Yanru
Fan, Xiao
Yang, Chen
Zhang, Lei
Wang, Qianyun
机构
[1] Soochow Univ, Dept Thorac Surg, Peoples Hosp Changzhou 1, Changzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 3, Changzhou, Peoples R China
关键词
Quality of life (QoL); robot-assisted thoracic surgery (RATS); lung cancer; LOBECTOMY;
D O I
10.21037/jtd-22-238
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: At present, research comparing robot-assisted thoracic surgery (RATS) and video-assisted thoracoscopic surgery (VATS) in lobectomy/segmentectomy for lung cancer is insufficient. This paper aimed to compare the safety, short-term efficacy, quality of life (QoL), and delayed complications at 6 weeks postoperatively via a retrospectively controlled study by a single surgeon. Methods: A total of 110 non-small cell lung cancer (NSCLC) cases from December 2020 to May 2021 were enrolled in this retrospective study, and were divided into RATS and VATS groups (both three-port procedures) according to the patients' preference. The propensity-score matching method was applied to control the potential differences. The patients were treated with lobectomy/segmentectomy for lung cancer by RATS or VATS, and the safety outcomes were evaluated. The follow-up was initiated after surgery, and the outcome assessments including hospitalization costs, short-term efficacy, pain and QoL, were collected and analyzed. Results: Both matched groups achieved a R0 resection rate of 100%. The average operation time of the RATS group was 21 minutes shorter than VATS (P<0.01), and the average hospitalization costs of the RATS group was 17,746 China Yuan higher than VATS (P<0.01). Furthermore, the visual analogue pain scores of the RATS group were lower than those of the VATS group at 1 day and 6 weeks postoperatively (2.53 +/- 0.86 vs. 3.88 +/- 0.88 and 0.35 +/- 0.65 vs. 0.74 +/- 0.88, respectively, P<0.05). Moreover, the core QoL scale score for cancer patients in the RATS group were higher than those of the VATS group at 6 weeks postoperatively (98.64 +/- 5.73 vs. 93.02 +/- 15.21, respectively, P<0.05). No significant differences were observed in the other indicators. Conclusions: Despite its high cost, RATS showed considerable potential for reducing the operation time and improving the QoL of patients. Meanwhile, RATS and VATS exhibited similar perioperative safety and short-term efficacy in lobectomy and segmentectomy.
引用
收藏
页码:689 / 698
页数:10
相关论文
共 13 条
[1]   Stage III Non-small Cell Lung Cancer Management in England [J].
Adizie, J. B. ;
Khakwani, A. ;
Beckett, P. ;
Navani, N. ;
West, D. ;
Woolhouse, I ;
Harden, S., V .
CLINICAL ONCOLOGY, 2019, 31 (10) :688-696
[2]   Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy [J].
Cao, Christopher ;
Louie, Brian E. ;
Melfi, Franca ;
Veronesi, Giulia ;
Razzak, Rene ;
Romano, Gaetano ;
Novellis, Pierluigi ;
Ranganath, Neel K. ;
Park, Bernard J. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 57 (02) :338-342
[3]   Compare the prognosis of Da Vinci robot-assisted thoracic surgery (RATS) with video-assisted thoracic surgery (VATS) for non-small cell lung cancer A Meta-analysis [J].
Guo, Feng ;
Ma, Dongjie ;
Li, Shanqing .
MEDICINE, 2019, 98 (39)
[4]   Surgical Treatment of Lung Cancer [J].
Hoy, Haley ;
Lynch, Thuy ;
Beck, Monica .
CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2019, 31 (03) :303-+
[5]   Efficacy and Safety of Robot-assisted Thoracic Surgery (RATS) Compare with Video-assisted Thoracoscopic Surgery (VATS) for Lung Lobectomy in Patients with Non-small Cell Lung Cancer [J].
Hu, Xun ;
Wang, Ming .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2019, 22 (03) :169-178
[6]   Robot-assisted thoracoscopic surgery versus thoracotomy for c-N2 stage NSCLC: short-term outcomes of a randomized trial [J].
Huang, Jia ;
Li, Chongwu ;
Li, Hecheng ;
Lv, Fanzhen ;
Jiang, Long ;
Lin, Hao ;
Lu, Peiji ;
Luo, Qingquan ;
Xu, Wenrong .
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) :951-958
[7]   Continuous 389 cases of Da Vinci robot-assisted thoracoscopic lobectomy in treatment of non-small cell lung cancer: experience in Shanghai Chest Hospital [J].
Huang, Jia ;
Li, Jiantao ;
Li, Hanyue ;
Lin, Hao ;
Lu, Peiji ;
Luo, Qingquan .
JOURNAL OF THORACIC DISEASE, 2018, 10 (06) :3776-3782
[8]   Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer [J].
Morrison, Eleshia J. ;
Novotny, Paul J. ;
Sloan, Jeff A. ;
Yang, Ping ;
Patten, Christi A. ;
Ruddy, Kathryn J. ;
Clark, Matthew M. .
CLINICAL LUNG CANCER, 2017, 18 (05) :497-503
[9]   Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial [J].
Suzuki, Kenji ;
Saji, Hisashi ;
Aokage, Keiju ;
Watanabe, Shun-ichi ;
Okada, Morihito ;
Mizusawa, Junki ;
Nakajima, Ryu ;
Tsuboi, Masahiro ;
Nakamura, Shinichiro ;
Nakamura, Kenichi ;
Mitsudomi, Tetsuya ;
Asamura, Hisao .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (03) :895-907
[10]   Is VATS lobectomy standard of care for operable non-small cell lung cancer? [J].
Vannucci, Fernando ;
Gonzalez-Rivas, Diego .
LUNG CANCER, 2016, 100 :114-119